Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Randal Shaheen Quoted in National Law Journal on FTC’s Regulatory Approach

Peter Roskam Comments on Political Climate in National Law Journal

ADventures in Law

Dark Patterns Go International: FTC and International Consumer Protection Networks Conduct Sweep of ‘Deceptive Design Practices’ Related to Subscription Services, Privacy

Jeff Paravano, Michelle Hervey, Nick Mowbray Speak to Tax Club of Cleveland

Partner <a href="http://www.bakerlaw.com/CarlWHittinger">Carl Hittinger</a> and Associate Lesley Grossberg co-authored an article in the April 30, 2015, issue of the <em>New Jersey Law Journal</em>. Titled “Refusals to Deal Still at Issue in ‘Celgene’ Case,” the article analyzes <em>Mylan Pharmaceuticals v. Celgene Corp., </em>pending in the U.S. District Court for the District of New Jersey, in which Mylan is alleging that Celgene’s refusal to provide it samples of two drugs it manufactures and sells amounts to unlawful monopolization under Section 2 of the Sherman Antitrust Act.

<a href="https://admin.bakerlaw.com/wp-content/uploads/2023/11/Hittinger-The-NJ-Law-Journal-May-4-15-Celgene.pdf" target="_blank" rel="noopener">Read the article.</a>

Hittinger, Grossberg Author Article on Drug makers’ Refusal-to-Deal Case

Featured Insights

Related Services

Featured Insights